Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts - PubMed (original) (raw)
Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
M Kellerer et al. Diabetes. 1994 Mar.
Abstract
Troglitazone (CS045), a compound belonging to the thiazolidine diones, is being tested as a new oral antidiabetic agent. Evidence exists from animal studies and clinical trials with non-insulin-dependent diabetes mellitus patients that Troglitazone might reduce insulin resistance. The molecular mechanism of this effect is not understood. In this study, we investigated whether Troglitazone might interfere with the mechanism of glucose-induced insulin resistance. Several studies indicate that hyperglycemia reduces the kinase activity of the insulin receptor in different cell types. This effect is paralleled by translocation of several protein kinase C (PKC) isoforms, and it can be prevented by PKC inhibitors, which suggests that glucose-induced receptor desensitization is mediated by activation of PKC. We studied the effect of hyperglycemia on the insulin receptor kinase activity and its modulation by Troglitazone in rat-1 fibroblasts that stably overexpress the human insulin receptor. Before stimulation with insulin (10(-7) M), cells were acutely exposed to hyperglycemic conditions in the absence or presence of Troglitazone (0.01-2 micrograms/ml). The insulin receptor was solubilized from a plasma membrane fraction or whole cell lysates, and proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted against antiphosphotyrosine and anti-insulin receptor beta-subunit (CT 104) antibodies. Acute hyperglycemia (25 mM glucose) induced a significant inhibition of the insulin receptor kinase (IRK) activity within 30 min (inhibition to 30 +/- 12.5% of maximal insulin-stimulated beta-subunit phosphorylation, n = 9, P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Troglitazone.
Spencer CM, Markham A. Spencer CM, et al. Drugs. 1997 Jul;54(1):89-101; discussion 102. doi: 10.2165/00003495-199754010-00010. Drugs. 1997. PMID: 9211083 Review. - Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells.
Müller HK, Kellerer M, Ermel B, Mühlhöfer A, Obermaier-Kusser B, Vogt B, Häring HU. Müller HK, et al. Diabetes. 1991 Nov;40(11):1440-8. doi: 10.2337/diab.40.11.1440. Diabetes. 1991. PMID: 1657668 - Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD, Higo K, Romeo OM, Lee MK, Rafaat K, Olefsky JM. Miles PD, et al. Diabetes. 1998 Mar;47(3):395-400. doi: 10.2337/diabetes.47.3.395. Diabetes. 1998. PMID: 9519745 - Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M, Spelleken M, Bock M, von Holtey M, Kiehn R, Eckel J. Bähr M, et al. Diabetologia. 1996 Jul;39(7):766-74. doi: 10.1007/s001250050509. Diabetologia. 1996. PMID: 8817100 - Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
Johnson MD, Campbell LK, Campbell RK. Johnson MD, et al. Ann Pharmacother. 1998 Mar;32(3):337-48. doi: 10.1345/aph.17046. Ann Pharmacother. 1998. PMID: 9533065 Review.
Cited by
- Modulation of insulin receptor signalling: significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation.
Häring HU, Kellerer M, Mosthaf L. Häring HU, et al. Diabetologia. 1994 Sep;37 Suppl 2:S149-54. doi: 10.1007/BF00400838. Diabetologia. 1994. PMID: 7821730 Review. - Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Okuno A, et al. J Clin Invest. 1998 Mar 15;101(6):1354-61. doi: 10.1172/JCI1235. J Clin Invest. 1998. PMID: 9502777 Free PMC article. - Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.
Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Häring H. Kroder G, et al. J Clin Invest. 1996 Mar 15;97(6):1471-7. doi: 10.1172/JCI118569. J Clin Invest. 1996. PMID: 8617880 Free PMC article. - Potential role of thiazolidinediones in older diabetic patients.
Umeda F. Umeda F. Drugs Aging. 1995 Nov;7(5):331-7. doi: 10.2165/00002512-199507050-00001. Drugs Aging. 1995. PMID: 8573988 Review. No abstract available. - Troglitazone.
Spencer CM, Markham A. Spencer CM, et al. Drugs. 1997 Jul;54(1):89-101; discussion 102. doi: 10.2165/00003495-199754010-00010. Drugs. 1997. PMID: 9211083 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical